Our leadership team believes that successful drug discovery requires focused collaboration, which we execute by working with our scientists and clinicians on unique populations and novel genomics. We actively seek collaborations with companies and foundations in order to leverage and complement resources and capabilities.
Meet the Director
Paul J. Kenny, PhD, is the Director of the Drug Discovery Institute and the Ward-Coleman Professor and Chair of the Dorothy H. and Lewis Rosenstiel Department of Pharmacology and Systems Therapeutics at the Icahn School of Medicine at Mount Sinai. Dr. Kenny is a world renowned researcher in the neurobiology of obesity and drug addiction. He has considerable drug development expertise and is one of only a handful of researchers in the United States who has had a drug licensed from an academic institution.
Dr. Kenny’s multidisciplinary research involves the study of behavioral paradigms, physiological analyses, and the molecular underpinnings of neurobehavioral disorders. He is actively investigating the brains of rodents to uncover new signaling cascades that may play a role in addiction-like behaviors.